BioCity Scotland, the centre for life science businesses in Newhouse, Lanarkshire has announced the appointment of Dr Allison Jeynes-Ellis MB ChB, FFPM as a new Board member. Formerly Medical and Innovation Director with the Association of British Pharmaceutical Industry, Dr Jeynes-Ellis will assume the position in September 2012

Over twenty years industry experience as an oncology specialist have equipped Dr Jeynes-Ellis with a unique insight into the complexities of the life sciences sector. Her early career within the NHS led to medical positions with, Ciba Pharmaceuticals, Bristol Myers Squibb as Director of Oncology and Wyeth, UK and Ireland as Medical Director. In 2005 Dr Jeynes-Ellis became an independent pharmaceutical consultant before moving to the ABPI in 2009. She has subsequently returned to consulting, working across the sector, allowing her to explore new opportunities such as that offered by BioCity Scotland.

As a Board member, Dr Jeynes-Ellis will support Chairman Dr Louis J Nisbet and recently-appointed Managing Director Fraser Black in the population of the 23 acre site with new and fast-growing bioscience and life sciences companies. BioCity Scotland has already welcomed seven companies to the site and has the support of six commercial partners including lawyers, accountants and intellectual property advisers. A variety of visitors has already passed through the busy campus including HRH The Princess Royal, international business delegations, and local school students eager to learn more about a career in science.

Commenting on her appointment Dr Jeynes-Ellis said, I am delighted to be part of this exciting opportunity for Scotland, as I strongly believe that BioCity Scotland can be instrumental in driving Scotland's continued success and further growth within the life science sector.

Dr Louis Nisbet, BioCity Scotland Chairman added, "We are delighted to welcome Allison to the Board of BCS. Her extensive experience with the pharmaceutical and biotechnology industries, coupled with her government and NHS relationships will be immensely valuable. With this she brings personal drive and great enthusiasm for building new life sciences companies in Scotland"

The existing BioCity Scotland board members are Dr Louis J. Nisbet (Chairman); Dr Glenn Crocker, CEO BioCity Group; Malcolm Bateman, CEO Roslin BioCentre; Ian Webster and Fraser Black, Managing Director BioCity Scotland.

For more information about BioCity Scotland visit www.biocity-scotland.co.uk